IL6 and lung cancer: Moreover, some cytokines have already been identified as predictive biomarkers of immunotherapy, such as plasma/serum IL6 levels in melanoma, non‐small cell lung cancer, kidney, breast, and bladder cancer patients treated with ICIs [9] or baseline serum IL‐8 levels in pancreatic cancer patients undergoing combined chemotherapy and immunotherapy [15].